SCHEMBL13005689

SCHEMBL13005689

CC(C)Cc1cccc(NC(=O)N(C)[C@@H](CC2CCCCC2)CN(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.43
ACKR3 P25106 2/20 0.41
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
EPHX2 P34913 2/20 0.38
EPHX1 P07099 1/20 0.38
F2RL1 P55085 1/20 0.38
REN P00797 1/20 0.38
CASR P41180 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
UBE2M P61081 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061039 0.90 SMN1; SMN2 (0.52) NPY5RSMN1; SMN2POLBRAB9AEPHX2
SCHEMBL13005674 0.83 SMN1; SMN2 (0.46) NPY5RSMN1; SMN2ACKR3RAB9AEPHX2
SCHEMBL13005597 0.76 ALDH1A1 (0.42) SMN1; SMN2ATMALDH1A1GAAL3MBTL1
SCHEMBL13005589 0.71 KMT2A (0.41) ALDH1A1GAAL3MBTL1PSEN1PSEN2
SCHEMBL13005671 0.71 F2 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13005486 0.69 F2 (0.39) RENATMALDH1A1GAAL3MBTL1
SCHEMBL13061126 0.69 NPC1 (0.54) POLBRAB9AEPHX2EPHX1NPC1
SCHEMBL13005624 0.69 MAPK1 (0.46)
SCHEMBL13005499 0.68 ALDH1A1 (0.36) RENALDH1A1GAAL3MBTL1PSEN1
SCHEMBL14752838 0.67 NPSR1 (0.55) POLBRAB9AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed